Zymaxid
- Generic Name: gatifloxacin ophthalmic solution
- Brand Name: Zymaxid
Zymaxid (Gatifloxacin Ophthalmic Solution) side effects drug center
Zymaxid Side Effects Center
What Is Zymaxid?
Zymaxid (gatifloxacin) Ophthalmic Solution 0.5% is a fluoroquinolone antibiotic used to treat bacterial conjunctivitis.
What Are Side Effects of Zymaxid?
Common side effects of Zymaxid include:
- eye irritation or pain,
- worsening of conjunctivitis, and
- changes in taste
Dosage for Zymaxid
The dose of Zymaxid is one drop instilled every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7.
What Drugs, Substances, or Supplements Interact with Zymaxid?
Zymaxid may interact with other drugs. Tell your doctor all medications and supplements you use.
Zymaxid During Pregnancy or Breastfeeding
During pregnancy, Zymaxid should be used only if prescribed. It is unknown if Zymaxid passes into breast milk. Consult your doctor before breastfeeding.
Additional Information
Our Zymaxid (gatifloxacin) Ophthalmic Solution 0.5% Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Zymaxid Consumer Information
Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; slow heart rate, weak pulse, fainting; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
- eye swelling, severe discomfort, crusting or drainage (may be signs of a new infection); or
- any new or worsening eye problems.
Common side effects may include:
- mild itching, burning, redness, or irritation;
- watery eyes; or
- puffy eyelids.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Zymaxid (Gatifloxacin Ophthalmic Solution)
Zymaxid Professional Information
SIDE EFFECTS
Clinical Studies Experience
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
In clinical studies with ZYMAXID® , the most frequently reported adverse reactions occurring in ≥ 1% of patients in the gatifloxacin study population (N=717) were: worsening of the conjunctivitis, eye irritation, dysgeusia, and eye pain.
Additional adverse events reported with other formulations of gatifloxacin ophthalmic solution include chemosis, conjunctival hemorrhage, dry eye, eye discharge, eyelid edema, headache, increased lacrimation, keratitis, papillary conjunctivitis, and reduced visual acuity.
Read the entire FDA prescribing information for Zymaxid (Gatifloxacin Ophthalmic Solution)
&Copy; Zymaxid Patient Information is supplied by Cerner Multum, Inc. and Zymaxid Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.